GlaxoSmithKline (GSK), one of the world’s leading research-based pharmaceutical company, is committed to improving the quality of human life by enabling people to do more, feel better and live longer. With a strong foundation and investment in research, GSK develops innovative medicines that help millions of people around the world. New treatments for cancer and prevention of cervical cancer are among some of the products currently in GSK’s R&D pipeline. Globally, GSK leads in respiratory, metabolic and alimentary, anti-infectives, and CNS – four of the five largest therapeutic areas worldwide. In addition, GSK is a key manufacturer of vaccines supplying a quarter of the world’s demand.
Merck & Co., Inc., which operates in many countries as Merck Sharp & Dohme
(MSD), is a global research-driven pharmaceutical company dedicated to
putting patients first. Established in 1891, Merck discovers, develops,
manufactures and markets vaccines and medicines in more than 20
therapeutic categories. The company devotes extensive efforts to increase
access to medicines through far-reaching programs that not only donate
Merck medicines but help deliver them to the people who need them. Merck
also publishes unbiased health information as a not-for-profit service.
For more information, visit www.merck.com.
Bronze Sponsor
Rockeby biomed Limited is a Singapore-based, ASX-listed (ASX : RBY) biotechnology
company specializing in research, development and marketing of rapid testing
technologies for infectious disease in humans and animals and lifestyle health products
including CanDia5® and Avian Influenza Virus test kits.
